Literature DB >> 8297701

Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy?

S C Grant1, S Sheldon, P A Dyer, R D Levy, N H Brooks.   

Abstract

BACKGROUND: The aetiology of idiopathic dilated cardiomyopathy is believed to have an immunological component. Association with human leucocyte antigens (HLAs) has been previously reported, particularly with HLA-DR4. AIM: To determine the association of HLA type with diagnosis in a group of patients assessed for heart transplantation.
METHODS: A comparison was made of frequencies of HLA types in patients with a diagnosis of idiopathic dilated cardiomyopathy or (n = 98) ischaemic heart disease (n = 170) and in controls from the North Western region (n = 857).
RESULTS: Neither the patients with idiopathic dilated cardiomyopathy nor those with ischaemic heart disease showed a significant increase or decrease in any HLA frequency compared with the controls.
CONCLUSION: These results suggest that there is no HLA association with idiopathic dilated cardiomyopathy or ischaemic heart disease. This conflicts with the results of some previous studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297701      PMCID: PMC483615          DOI: 10.1136/hrt.71.1.76

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  15 in total

1.  Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy.

Authors:  R E Fowles; C P Bieber; E B Stinson
Journal:  Circulation       Date:  1979-03       Impact factor: 29.690

2.  HLA-DRw6 antigen linkage in chronic congestive heart failure secondary to coronary artery disease (ischemic cardiomyopathy).

Authors:  C J Limas; C Limas
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

3.  Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy.

Authors:  R Gerli; P Rambotti; F Spinozzi; A Bertotto; V Chiodini; P Solinas; I Gernini; S Davis
Journal:  Am Heart J       Date:  1986-08       Impact factor: 4.749

4.  Associations of HLA-A, B, DR antigens with primary disease in cardiac allograft recipients.

Authors:  T R Zerbe; C Kaufmann; Y Colson; R Duquesnoy
Journal:  Am J Cardiol       Date:  1988-06-01       Impact factor: 2.778

5.  Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

6.  Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

Authors:  J L Anderson; J F Carlquist; E H Hammond
Journal:  Lancet       Date:  1982-11-20       Impact factor: 79.321

7.  Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.

Authors:  C J Limas; I F Goldenberg; C Limas
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

8.  The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes.

Authors:  E Arbustini; A Gavazzi; R Pozzi; M Grasso; A Pucci; C Campana; G Graziano; M Martinetti; M Cuccia; L Salvaneschi
Journal:  Am J Cardiol       Date:  1989-11-01       Impact factor: 2.778

9.  HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors.

Authors:  J L Anderson; J F Carlquist; J R Lutz; C W DeWitt; E H Hammond
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

10.  [HLA A-B and DR in dilated myocardiopathies].

Authors:  M Komajda; C Raffoux; E Salame; J Colombani; Y Grosgogeat; C Cabrol; J Dausset
Journal:  Arch Mal Coeur Vaiss       Date:  1987-07
View more
  3 in total

1.  Idiopathic dilated cardiomyopathy: familial prevalence and HLA distribution.

Authors:  C J McKenna; M B Codd; H A McCann; D D Sugrue
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy.

Authors:  Bo Jin; Xin-Ping Luo; Huan-Chun Ni; Wei Shen; Hai-Ming Shi; Yong Li
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

Review 3.  HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy.

Authors:  B Jin; B W Wu; Z C Wen; H M Shi; J Zhu
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.